Stay updated on Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.2 is now shown in the page history, replacing v3.3.1. This update does not alter any study records or displayed information on the page.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision: v3.3.1 was added to the page's history, and Revision: v3.2.0 was removed. The changes pertain to the page’s revision log rather than study information.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the general government funding/status banner from the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedThe new screenshot shows updated version history entries and timestamps in the Record History, while the core trial content (status, contacts, locations, and other details) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference9%

Stay in the know with updates to Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.